Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00473551
Status:
TERMINATED
Last Update Posted:
2011-12-19
First Post:
2007-05-11
Brief Title:
Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myeloma |
| Leukemia |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| Chronic Lymphocytic Leukemia | View |
| Lymphoma | View |
| Myeloma | View |
| Leukemia | View |
| Anti-Third Party Cytolytic Lymphocytes | View |
| Indolent Lymphoid Malignancies | View |
| Fludarabine | View |
| Fludara | View |
| Rituximab | View |
| Rituxan | View |
| Cyclophosphamide | View |
| Cytoxan | View |
| Neosar | View |
| Stem Cell Transplantation | View |
| T-lymphocytes | View |
| Miltenyi CliniMACS System | View |
| Graft vs Host Disease | View |
| GVHD | View |
| Allogenic Transplant | View |
| Sirolimus | View |
| Rapamycin | View |